Neuronetics (STIM) Interest Coverage Ratio Growth (5y) (2022 - 2026)
Neuronetics (STIM) Interest Coverage Ratio Growth (5y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.55 Bn | 176.26 Bn | 6.27 Bn |
| 2 | Stryker | 128.64 Bn | 125.76 Bn | 3.81 Bn |
| 3 | Medtronic | 108.92 Bn | 99.70 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.50 Bn | 67.05 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.84 Bn | 44.17 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.25 Bn | 25.96 Bn | 1.98 Bn |
| 7 | Dexcom | 28.23 Bn | 27.11 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.30 Bn | 2.07 Bn |
| 10 | Neuronetics | 121.78 Mn | 115.77 Mn | 16.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -52.90% |
| Dec 31, 2025 | -3.99% |
| Sep 30, 2025 | -28.46% |
| Jun 30, 2025 | 35.20% |
| Mar 31, 2025 | 6.39% |
| Dec 31, 2024 | 3.16% |
| Sep 30, 2024 | -44.08% |
| Jun 30, 2024 | -69.56% |
| Mar 31, 2024 | 13.32% |
| Dec 31, 2023 | 15.15% |
| Sep 30, 2023 | -169.85% |
| Jun 30, 2023 | -148.41% |
| Mar 31, 2023 | -9.60% |
| Dec 31, 2022 | 5.06% |
| Sep 30, 2022 | -11.18% |
| Jun 30, 2022 | -15.89% |
| Mar 31, 2022 | 22.92% |